Cite
HARVARD Citation
Gettinger, S. et al. (n.d.). 81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases. Lung cancer. 87 (1), pp. S32-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gettinger, S. et al. (n.d.). 81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases. Lung cancer. 87 (1), pp. S32-. [Online].